Sulbactam
is a β-lactamase inhibitor accustomed in aggregate with β-lactam antibiotics to
arrest β-lactamase, an agitator produced by bacilli that destroys antibacterial
activity.
Sulbactam
is currently accessible in aggregate articles with ampicillin. Within this
conception it is adumbrated for the analysis of infections due to affected
strains of the appointed microorganisms in the altitude listed below. Skin and
Skin Structure Infections acquired by beta-lactamase bearing strains of
Staphylococcus aureus, Escherichia coli, Klebsiella spp. (including K.
pneumoniae), Proteus mirabilis, Bacteroides fragilis, Enterobacter spp., and
Acinetobacter calcoaceticus. Intra-Abdominal Infections acquired by
beta-lactamase bearing strains of Escherichia coli, Klebsiella spp. (including
K. pneumoniae), Bacteroides spp. (including B. fragilis), and Enterobacter spp.
Gynecological Infections acquired by beta-lactamase bearing strains of
Escherichia coli, and Bacteroides spp.
No comments:
Post a Comment